This inventor holds 1 USPTO granted patent. Top assignee: Alpha-9 Oncology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Kostelnik: Innovator in Radiopharmaceuticals
Introduction
Thomas Kostelnik is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative work at Alpha-9 Oncology Inc. His expertise and dedication to advancing medical technology have led to the development of valuable patents.
Latest Patents
Kostelnik holds a patent for "Stable Radiopharmaceutical Compositions and Uses Thereof." This invention represents a crucial advancement in the field, providing new methods and compositions that enhance the effectiveness of radiopharmaceuticals in medical applications. He has 1 patent to his name, showcasing his commitment to innovation.
Career Highlights
Throughout his career, Thomas Kostelnik has focused on the intersection of chemistry and medicine. His work at Alpha-9 Oncology Inc. has positioned him as a key player in the development of new therapeutic options for cancer treatment. His contributions have been instrumental in pushing the boundaries of what is possible in radiopharmaceutical technology.
Collaborations
Kostelnik has collaborated with talented professionals in his field, including Alison Fleming and Imma Carbo-Bague. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thomas Kostelnik is a distinguished inventor whose work in radiopharmaceuticals has the potential to transform cancer treatment. His patent and collaborations reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile